Why it works
Kratom acts on opioid receptors — so does buprenorphine.
Kratom's active compounds, including mitragynine and 7-hydroxymitragynine (7-OH), bind to mu-opioid receptors. Buprenorphine is a partial mu-opioid agonist with very high receptor affinity — it binds tightly to those same receptors and occupies them, which suppresses withdrawal and reduces the pull toward continued kratom use.
This is the same mechanism by which buprenorphine treats opioid use disorder from heroin, fentanyl, or prescription opioids. The receptor targets are the same.
What to expect
Withdrawal from kratom is real but manageable.
Kratom withdrawal typically includes muscle aches, irritability, insomnia, sweating, and strong cravings. The severity depends on how much kratom was used, how frequently, and for how long. 7-OH use tends to produce more intense withdrawal than high-dose kratom leaf products.
Buprenorphine addresses most of these symptoms directly. Most patients feel meaningfully better within the first day of treatment. Induction timing varies — your physician will guide you on when to start based on your last kratom use and how you are feeling.
Evidence
Published case reports support buprenorphine for kratom withdrawal.
Multiple published case series and reports describe successful use of buprenorphine for kratom and 7-OH withdrawal. This is an evolving area — kratom dependence is increasingly recognized clinically, and the evidence base continues to grow. Buprenorphine is one of the medications that has been used in clinical settings for kratom and 7-OH dependence.
Treatment
Treatment is available through online visits.
MyStreetHealth treats kratom and 7-OH dependence through secure telehealth visits in Virginia, West Virginia, Maryland, Washington DC, and Ohio. No insurance required. Same-day visits usually available.
If you're planning a transition, see how to switch from kratom to Suboxone →